(CTVA) Corteva - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US22052L1044

CTVA: Seeds, Herbicides, Insecticides, Fertilizers, Pest Control, Digital

Corteva, Inc. (NYSE:CTVA) is a global leader in agricultural solutions, operating through two core segments: Seed and Crop Protection. The Seed segment specializes in developing high-performance germplasm and traits designed to maximize yield and resilience. It offers advanced technologies that enhance resistance to environmental stressors, diseases, insects, and herbicides, while also improving nutritional quality. Additionally, this segment provides precision agriculture tools that leverage data analytics to optimize planting decisions, yield potential, and profitability. The Crop Protection segment delivers a comprehensive portfolio of solutions to safeguard crops from weeds, insects, pests, and diseases. It also focuses on enhancing soil and plant health through innovations in nitrogen management and seed-applied technologies. Key offerings include herbicides, insecticides, fungicides, and pasture management solutions. Corteva serves the agricultural input industry worldwide, with operations spanning the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. Headquartered in Indianapolis, Indiana, the company was established in 2018 as an independent entity following its separation from DowDuPont. Web URL: https://www.corteva.com.

As of the latest data, Corteva, Inc. is categorized under the Fertilizers & Agricultural Chemicals sub-industry, listed on the NYSE under the ticker symbol CTVA. The companys current market capitalization stands at $38,105.41 million USD, with a price-to-earnings (P/E) ratio of 45.73 and a forward P/E of 19.16. Its price-to-book (P/B) ratio is 1.60, and the price-to-sales (P/S) ratio is 2.25. The return on equity (RoE) is reported at 3.81%. Technically, the stocks average 20-day volume is 3,097,035 shares, with a last price of $59.74. Key moving averages include the SMA 20 at $60.26, SMA 50 at $61.16, and SMA 200 at $58.28. The average true range (ATR) is 1.86.

3-Month Forecast (Based on Technical and Fundamental Data): - Technical Outlook: The stock is currently trading near its 20-day SMA ($60.26), indicating potential resistance. The SMA 50 ($61.16) and SMA 200 ($58.28) suggest a narrowing range, with the stock oscillating around these levels. A break above $61.16 could signal upward momentum, while a drop below $58.28 may indicate a downtrend. The ATR of 1.86 suggests moderate volatility. - Fundamental Outlook: With a forward P/E of 19.16, the stock is priced at a premium, reflecting expectations of future growth. The P/S ratio of 2.25 aligns with industry averages, indicating reasonable valuation relative to sales. A Market Cap of $38,105.41M underscores Cortevas market leadership in the agricultural chemicals sector. The RoE of 3.81% suggests modest profitability, but the companys focus on innovation and global distribution could drive future returns.

Additional Sources for CTVA Stock

CTVA Stock Overview

Market Cap in USD 40,803m
Sector Basic Materials
Industry Agricultural Inputs
GiC Sub-Industry Fertilizers & Agricultural Chemicals
IPO / Inception 2019-05-24

CTVA Stock Ratings

Growth Rating 77.5
Fundamental 17.9
Dividend Rating 57.7
Rel. Strength 19.3
Analysts 4.26/5
Fair Price Momentum 61.59 USD
Fair Price DCF 90.46 USD

CTVA Dividends

Dividend Yield 12m 1.14%
Yield on Cost 5y 2.71%
Annual Growth 5y 4.88%
Payout Consistency 100.0%

CTVA Growth Ratios

Growth Correlation 3m -71.6%
Growth Correlation 12m 78.1%
Growth Correlation 5y 73.3%
CAGR 5y 19.69%
CAGR/Max DD 5y 0.57
Sharpe Ratio 12m -0.32
Alpha 4.86
Beta 0.780
Volatility 26.44%
Current Volume 1652.2k
Average Volume 20d 3097k
What is the price of CTVA stocks?
As of April 23, 2025, the stock is trading at USD 60.65 with a total of 1,652,198 shares traded.
Over the past week, the price has changed by +1.59%, over one month by -2.29%, over three months by -2.71% and over the past year by +11.13%.
Is Corteva a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Corteva is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 17.86 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CTVA as of April 2025 is 61.59. This means that CTVA is currently overvalued and has a potential downside of 1.55%.
Is CTVA a buy, sell or hold?
Corteva has received a consensus analysts rating of 4.26. Therefor, it is recommend to buy CTVA.
  • Strong Buy: 12
  • Buy: 5
  • Hold: 6
  • Sell: 0
  • Strong Sell: 0
What are the forecast for CTVA stock price target?
According to ValueRays Forecast Model, CTVA Corteva will be worth about 67.6 in April 2026. The stock is currently trading at 60.65. This means that the stock has a potential upside of +11.53%.
Issuer Forecast Upside
Wallstreet Target Price 69.1 13.9%
Analysts Target Price 66.4 9.4%
ValueRay Target Price 67.6 11.5%